Article Text

Download PDFPDF
CASE REPORT
Idiopathic catastrophic thrombosis with happy ending
  1. Julia Heid1,
  2. Andreas Greinacher2,
  3. Hugo A Katus1,
  4. Oliver J Müller1,3
  1. 1Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany
  2. 2Institute for Immunology and Transfusion Medicine, Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Germany
  3. 3Department of Cardiology, Angiology and Intensive Care Medicine, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany
  1. Correspondence to Professor Oliver J Müller, oliver.mueller{at}uksh.de

Summary

A 59-year-old male patient suffered three life-threatening instent thromboses after an initial resuscitation due to an ST-segment elevation myocardial infarction of the anterior cardiac wall. With a high-risk profile for heparin-induced thrombocytopenia (HIT), he was placed on argatroban after the second reinfarction. Under this apparently appropriate treatment, a third reinfarction occurred, and the patient had to undergo high-risk cardiac bypass surgery. Later on, a deep vein thrombosis and an intracardiac thrombus formed. Despite a positive screening test for HIT and a single positive result in the heparin-induced platelet aggregation test, we are not convinced that HIT was the only underlying cause for this ‘catastrophic thrombotic syndrome’. We speculate that a massive generation of thrombin, reflected in consistently high D dimers and the need of copious amounts of a direct thrombin inhibitor, triggered the set of events. With this case report, we want to raise awareness for cardiac complications in patients with complex clotting disorders and share our experience in the diagnostic and therapeutic management of such an unusual scenario.

  • interventional cardiology
  • ischaemic heart disease
  • venous thromboembolism
  • clinical diagnostic tests
  • adult intensive care

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors The manuscript was written by JH and OJM and critically revised by AG and HAK.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.